logo image


Stanlip 145 145mg




Stanlip 145 FC-TAB



Stanlip 145 from Ranbaxy (Cardiovasculars) contains Fenofibrate

Below are some of the details of Fenofibrate(generic)

Fenofibrate is a drug of the fibrate class. Fenofibrate was discovered by Groupe Fournier SA, before it was acquired in 2005 by Solvay Pharmaceutical, a business unit owned by the Belgian corporation, Solvay S.A. It is mainly used to reduce cholesterol levels in patients at risk of cardiovascular disease. Like other fibrates, it reduces both low-density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels, as well as increasing high-density lipoprotein (HDL) levels and reducing tryglycerides level. It also appears to have a beneficial effect on the insulin resistance featured by the metabolic syndrome. It is used alone or in conjunction with statins in the treatment of hypercholesterolemia and hypertriglyceridemia. Fenofibrate is sold under the brand name Tricor and Trilipix by Abbott Labs, Lipofen by Kowa Pharmaceuticals America Inc, Lofibra by Teva, Lipanthyl and Lipidil by Solvay Pharmaceutical, Fenocor-67 by Ordain Health Care Pvt Ltd and Fenogal by SMB Laboratories

More vital info on Stanlip 145’s generic

© 2011-2018 DrugsUpdate.com. Disclaimer | Site Map